FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Cardiac Ablation Percutaneous Catheter

PMA: P960016 · Supplement: S092 · Decision Apr 10, 2025
Classifications
1
FEI Numbers
52
Registration Numbers
52

Basic Information

Device Name
Cardiac Ablation Percutaneous Catheter
Trade Name
Safire™ Bi-Directional Ablation Catheter; Safire™ Catheter Extension Cable
PMA Number
P960016
Supplement Number
S092
Device Class
FDA Class 3
Product Code
LPB
Generic Name
Cardiac ablation percutaneous catheter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
April 10, 2025
Date Received
March 12, 2025
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

an expansion of sterilization capabilities, including validation of the maximum load configuration, an addition of preconditioning room, and parametric release for Cycle 219 at Centerpiece in Tijuana, Mexico

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LPB Cardiac Ablation Percutaneous Catheter